X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12977) 12977
Book Review (3469) 3469
Publication (509) 509
Book Chapter (109) 109
Newsletter (96) 96
Magazine Article (31) 31
Newspaper Article (17) 17
Book / eBook (10) 10
Conference Proceeding (8) 8
Dissertation (8) 8
Trade Publication Article (4) 4
Reference (2) 2
Paper (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10934) 10934
humans (9947) 9947
female (4979) 4979
male (4760) 4760
heparin (4310) 4310
molecular-weight heparin (3433) 3433
anticoagulants - therapeutic use (3242) 3242
middle aged (3114) 3114
anticoagulants - administration & dosage (2837) 2837
aged (2809) 2809
anticoagulants (2626) 2626
hematology (2617) 2617
adult (2469) 2469
peripheral vascular disease (2272) 2272
heparin, low-molecular-weight - administration & dosage (2246) 2246
heparin, low-molecular-weight - therapeutic use (2142) 2142
thrombosis (2050) 2050
anticoagulants - adverse effects (2007) 2007
risk factors (1967) 1967
venous thromboembolism (1909) 1909
unfractionated heparin (1897) 1897
animals (1886) 1886
thromboembolism (1827) 1827
treatment outcome (1806) 1806
heparin - therapeutic use (1740) 1740
heparin - administration & dosage (1736) 1736
prevention (1730) 1730
abridged index medicus (1726) 1726
surgery (1649) 1649
deep-vein thrombosis (1627) 1627
heparin - adverse effects (1455) 1455
enoxaparin (1320) 1320
pharmacology & pharmacy (1225) 1225
cardiac & cardiovascular systems (1179) 1179
drug therapy (1089) 1089
heparin, low-molecular-weight - adverse effects (1055) 1055
aged, 80 and over (1052) 1052
fibrinolytic agents - therapeutic use (1043) 1043
medicine, general & internal (1029) 1029
pregnancy (1029) 1029
anticoagulation (1012) 1012
care and treatment (959) 959
thromboembolism - prevention & control (959) 959
medicine & public health (946) 946
warfarin (938) 938
prospective studies (928) 928
venous thrombosis (928) 928
therapy (920) 920
time factors (920) 920
prophylaxis (914) 914
low molecular weight heparin (911) 911
retrospective studies (910) 910
venous thrombosis - prevention & control (897) 897
hemorrhage - chemically induced (895) 895
dose-response relationship, drug (865) 865
postoperative complications - prevention & control (845) 845
pulmonary-embolism (831) 831
venous thrombosis - drug therapy (822) 822
pulmonary embolism (817) 817
heparin - pharmacology (793) 793
risk (793) 793
thrombocytopenia - chemically induced (790) 790
health aspects (788) 788
analysis (785) 785
glycosaminoglycans (767) 767
anticoagulants - pharmacology (762) 762
low-molecular-weight heparin (754) 754
venous thromboembolism - prevention & control (752) 752
fibrinolytic agents - administration & dosage (733) 733
drug administration schedule (690) 690
research (685) 685
management (678) 678
thrombosis - prevention & control (674) 674
rats (671) 671
administration, oral (666) 666
cancer (665) 665
injections, subcutaneous (658) 658
molecular weight (641) 641
heparin-induced thrombocytopenia (627) 627
blood coagulation - drug effects (621) 621
dosage and administration (613) 613
risk assessment (606) 606
thromboprophylaxis (601) 601
aspirin (600) 600
enoxaparin - administration & dosage (600) 600
diagnosis (575) 575
complications (563) 563
partial thromboplastin time (552) 552
heparin, low-molecular-weight - pharmacology (548) 548
factor xa inhibitors (546) 546
adolescent (541) 541
cardiology (535) 535
mortality (534) 534
enoxaparin - therapeutic use (530) 530
randomized controlled trials as topic (528) 528
thrombin (513) 513
thrombocytopenia (506) 506
coagulation (500) 500
pulmonary embolism - prevention & control (495) 495
incidence (490) 490
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12311) 12311
German (321) 321
French (250) 250
Spanish (78) 78
Japanese (37) 37
Russian (34) 34
Polish (28) 28
Chinese (24) 24
Italian (20) 20
Czech (18) 18
Hungarian (17) 17
Norwegian (15) 15
Dutch (13) 13
Swedish (13) 13
Danish (12) 12
Bulgarian (8) 8
Portuguese (8) 8
Turkish (6) 6
Croatian (5) 5
Serbian (4) 4
Finnish (3) 3
Korean (3) 3
Lithuanian (2) 2
Arabic (1) 1
Bosnian (1) 1
Romanian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes, ISSN 0012-1797, 09/2006, Volume 55, Issue 9, pp. 2510 - 2522
Journal Article
Journal Article
BMC Research Notes, ISSN 1756-0500, 09/2014, Volume 7, Issue 1, pp. 586 - 586
Journal Article
Obesity Surgery, ISSN 0960-8923, 1/2012, Volume 22, Issue 1, pp. 47 - 51
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 09/2014, Volume 189, pp. 80 - 89
Here, we report reduced graphene oxide (rGO) nanosheets coated with an anti-angiogenic anticancer taurocholate derivative of low-molecular-weight heparin... 
Anticancer effect | Reduced graphene oxide | Doxorubicin | Anti-angiogenic anticancer low molecular weight heparin derivative | Dispersion stability | DISPERSIONS | VIVO | CHEMISTRY, MULTIDISCIPLINARY | FUNCTIONALIZATION | IN-VITRO | CO-DELIVERY | THERAPY | TAUROCHOLATE CONJUGATE | PHARMACOLOGY & PHARMACY | BIOMEDICAL APPLICATIONS | Heparin, Low-Molecular-Weight - analogs & derivatives | Humans | Drug Carriers - administration & dosage | Doxorubicin - chemistry | Antineoplastic Agents - administration & dosage | Drug Carriers - chemistry | Graphite - administration & dosage | Female | Taurocholic Acid - chemistry | Graphite - chemistry | Taurocholic Acid - analogs & derivatives | Doxorubicin - administration & dosage | Cell Survival - drug effects | Oxidation-Reduction | Drug Stability | Heparin, Low-Molecular-Weight - chemistry | Antineoplastic Agents - chemistry | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Taurocholic Acid - administration & dosage | Adsorption | Tumor Burden - drug effects | Mice, Nude | Nanostructures - administration & dosage | Cell Line, Tumor | Nanostructures - chemistry | Mice, Inbred BALB C | Heparin, Low-Molecular-Weight - administration & dosage | Neoplasms - pathology | Antimitotic agents | Glycosaminoglycans | Graphene | Fluorescein | Graphite | Anticoagulants (Medicine) | Antineoplastic agents | Anthracyclines | Pharmacy | Fluorescence | Tumors | Index Medicus
Journal Article